


Carcell Biopharma Revenue
Biotechnology Research • Pudong, Shanghai, China • 1-10 Employees
Carcell Biopharma revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,200,000 |
| Total funding | No funding |
Key Contacts at Carcell Biopharma
Xiangqian Lin
Founder
Lijun Xu
Senior Director Human Resources
Joey Cheng
Associate Director Of Finance
Company overview
| Headquarters | #166 Meiyue Road, Blk 122, Level 2, Shanghai Pilot Free-Trade Zone, Shanghai, 201208, CN |
| Website | |
| NAICS | 541714 |
| Keywords | Biotech, Delivery Technologies, Lipid Nanoparticle, Red Cell Therapy |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
About Carcell Biopharma
Carcell Biopharma ("Carcell") is a global biotech company launched by EVX Ventures. With an innovative “hub-and-spoke” business model, Carcell accelerates innovations in and translation of next-generation cell and gene therapies. Carcell has two lead technology platforms. The first technological platform creates engineered red blood cells (eRBC) for allogeneic cell therapy against autoimmune diseases and cancer. The second technological platform is a lipid nanoparticle (LNP) platform that has a proprietary library and high throughput screening capabilities for effective nucleic acid delivery.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Carcell Biopharma has 3 employees across 3 departments.
Departments
Number of employees
Carcell Biopharma Tech Stack
Discover the technologies and tools that power Carcell Biopharma's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Tag managers
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
Analytics
CDN
Frequently asked questions
4.8
40,000 users



